No retraction, correction or concern found when last checked on Oct 20, 2026.
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang and 14 more
Molecular Biomedicine · 2023 · Review · CC BY
doi:10.1186/s43556-023-00142-2
Abstract
Ferroptosis, a regulated form of cellular death characterized by the iron-mediated accumulation of lipid peroxides, provides a novel avenue for delving into the intersection of cellular metabolism, oxidative stress, and disease pathology. We have witnessed a mounting fascination with ferroptosis, attributed to its pivotal roles across diverse physiological and pathological conditions including developmental processes, metabolic dynamics, oncogenic pathways, neurodegenerative cascades, and traumatic tissue injuries. By unraveling the intricate underpinnings of the molecular machinery, pivotal contributors, intricate signaling conduits, and regulatory networks governing ferroptosis, researchers aim to bridge the gap between the intricacies of this unique mode of cellular death and its multifaceted implications for health and disease. In light of the rapidly advancing landscape of ferroptosis research, we present a comprehensive review aiming at the extensive implications of ferroptosis in the origins and progress of human diseases. This review concludes with a careful analysis of potential treatment approaches carefully designed to either inhibit or promote ferroptosis. Additionally, we have succinctly summarized the potential therapeutic targets and compounds that hold promise in targeting ferroptosis within various diseases. This pivotal facet underscores the burgeoning possibilities for manipulating ferroptosis as a therapeutic strategy. In summary, this review enriched the insights of both investigators and practitioners, while fostering an elevated comprehension of ferroptosis and its latent translational utilities. By revealing the basic processes and investigating treatment possibilities, this review provides a crucial resource for scientists and medical practitioners, aiding in a deep understanding of ferroptosis and its effects in various disease situations.
References 861
- 1.
- 2.
Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26(9–10):512-533.
Not in our library10.1007/s10495-021-01687-9
- 3.
Raj S, Jaiswal SK, DePamphilis ML. Cell death and the p53 enigma during mammalian embryonic development. Stem Cells. 2022;40(3):227-238.
Not in our library10.1093/stmcls/sxac003
- 4.
Kist M, Vucic D. Cell death pathways: intricate connections and disease implications. EMBO J. 2021;40(5):e106700.
Not in our library10.15252/embj.2020106700
- 5.
Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285-296.
Not in our library10.1016/s1535-6108(03)00050-3
- 6.
Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234-245.
Not in our library10.1016/j.chembiol.2008.02.010
- 7.
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072.
Not in our library10.1016/j.cell.2012.03.042
- 8.
Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57-62.
Not in our library10.1038/nature14344
- 9.
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266-282.
Not in our library10.1038/s41580-020-00324-8
- 10.
- 11.
Stockwell SJDaBR. The hallmarks of ferroptosis. Annu Rev Cancer Biol. 2019; 2019. 3:35–54. doi:10.1146/annurev-.
Not in our library10.1146/annurev-cancerbio-030518-055844
- 12.
- 13.
Feng H, Schorpp K, Jin J, Yozwiak CE, Hoffstrom BG, Decker AM, et al. Transferrin receptor is a specific ferroptosis marker. Cell Rep. 2020;30(10):3411-23 e7.
Not in our library10.1016/j.celrep.2020.02.049
- 14.
Schiavi A, Salveridou E, Brinkmann V, Shaik A, Menzel R, Kalyanasundaram S, et al. Mitochondria hormesis delays aging and associated diseases in Caenorhabditis elegans impacting on key ferroptosis players. iScience. 2023;26(4):106448.
Not in our library10.1016/j.isci.2023.106448
- 15.
Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365-78.e6.
Not in our library10.1016/j.ccell.2022.02.003
- 16.
Muller S, Sindikubwabo F, Caneque T, Lafon A, Versini A, Lombard B, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12(10):929-938.
Not in our library10.1038/s41557-020-0513-5
- 17.
Wang Y, Zhang M, Bi R, Su Y, Quan F, Lin Y, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 2022;51:102262.
Not in our library10.1016/j.redox.2022.102262
- 18.
Schreiber R, Buchholz B, Kraus A, Schley G, Scholz J, Ousingsawat J, et al. Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A. J Am Soc Nephrol. 2019;30(2):228-242.
Not in our library10.1681/asn.2018010039
- 19.
Maser RL, Vassmer D, Magenheimer BS, Calvet JP. Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease. J Am Soc Nephrol. 2002;13(4):991-999.
Not in our library10.1681/asn.v134991
- 20.
Zhou Z, Ye TJ, DeCaro E, Buehler B, Stahl Z, Bonavita G, et al. Intestinal SIRT1 deficiency protects mice from ethanol-induced liver injury by mitigating ferroptosis. Am J Pathol. 2020;190(1):82-92.
Not in our library10.1016/j.ajpath.2019.09.012
- 21.
Wang J, Zhu Q, Li R, Zhang J, Ye X, Li X. YAP1 protects against septic liver injury via ferroptosis resistance. Cell Biosci. 2022;12(1):163.
Not in our library10.1186/s13578-022-00902-7
- 22.
- 23.
Belaidi AA, Gunn AP, Wong BX, Ayton S, Appukuttan AT, Roberts BR, et al. Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice. Neurotherapeutics. 2018;15(4):1055-1062.
Not in our library10.1007/s13311-018-0656-x
- 24.
Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177(5):1262-79 e25.
Not in our library10.1016/j.cell.2019.03.032
- 25.
- 26.
Yu X, Ma X, Lyu J, Jiang N, Lu Y, Liao Y, et al. Ferroptosis involved in sevoflurane-aggravated young rats brain injury induced by liver transplantation. NeuroReport. 2022;33(16):705-713.
Not in our library10.1097/wnr.0000000000001836
- 27.
Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672-2680.
Not in our library10.1073/pnas.1821022116
- 28.
Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M, et al. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2018;314(3):H659-H668.
Not in our library10.1152/ajpheart.00452.2017
- 29.
Liu Y, Zeng L, Yang Y, Chen C, Wang D, Wang H. Acyl-CoA thioesterase 1 prevents cardiomyocytes from Doxorubicin-induced ferroptosis via shaping the lipid composition. Cell Death Dis. 2020;11(9):756.
Not in our library10.1038/s41419-020-02948-2
- 30.
Zang J, Cui M, Xiao L, Zhang J, Jing R. Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer. Clin Transl Oncol. 2023. 10.1007/s12094-023-03136-2.
Not in our library10.1007/s12094-023-03136-2
- 31.
Panda SK, Peng V, Sudan R, Ulezko Antonova A, Di Luccia B, Ohara TE, et al. Repression of the aryl-hydrocarbon receptor prevents oxidative stress and ferroptosis of intestinal intraepithelial lymphocytes. Immunity. 2023;56(4):797-812.e4.
Not in our library10.1016/j.immuni.2023.01.023
- 32.
Yan Q, Zheng W, Jiang Y, Zhou P, Lai Y, Liu C, et al. Transcriptomic reveals the ferroptosis features of host response in a mouse model of Zika virus infection. J Med Virol. 2023;95(1):e28386.
Not in our library10.1002/jmv.28386
- 33.
Sawicki KT, De Jesus A, Ardehali H. Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res. 2023;132(3):379-396.
Not in our library10.1161/circresaha.122.321667
- 34.
Zeng F, Ye L, Zhou Q, He Y, Zhang Y, Deng G, et al. Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis. Redox Biol. 2023;61:102653.
Not in our library10.1016/j.redox.2023.102653
- 35.
- 36.
Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 2018;128(8):3341-3355.
Not in our library10.1172/jci99032
- 37.
- 38.
- 39.
Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7-23.
Not in our library10.1038/s41569-022-00735-4
- 40.
Cited by papers we hold 1
- In defence of ferroptosis · 2025No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.